Intraoperative cell salvage during cardiac surgery is associated with reduced postoperative lung injury

Interactive Cardiovascular and Thoracic Surgery

Volumn 22, Issue 3, 2016, Pages 298-304

  Engels, Gerwin E ^a   Van Klarenbosch, Jan ^b   Gu, Y John ^c   Van Oeveren, Willem ^a,c   De Vries, Adrianus J ^c  

^a HaemoScan BV   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Extracorporeal circulationd; Lung

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CLARA CELL 16 PROTEIN; CLARA CELL PROTEIN; ELASTASE; INTERLEUKIN 6; LIPID; MYELOPEROXIDASE; SURFACTANT PROTEIN D; UNCLASSIFIED DRUG; AGER PROTEIN, HUMAN; AUTACOID; BIOLOGICAL MARKER; CYTOKINE; SCGB1A1 PROTEIN, HUMAN; UTEROGLOBIN;

AGED; ARTICLE; ARTIFICIAL VENTILATION; AUTOTRANSFUSION UNIT; BLOOD SAMPLING; CAPILLARY WALL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; ENZYME BLOOD LEVEL; FEMALE; HEART SURGERY; HUMAN; INFLAMMATION; LEUKOCYTE ACTIVATION; LIPID BLOOD LEVEL; LUNG ALVEOLUS OXYGEN TENSION; LUNG INJURY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PEROPERATIVE CARE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; ADVERSE EFFECTS; BLOOD; BLOOD SALVAGE; CLINICAL TRIAL; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME;

ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; AGED; BIOMARKERS; CARDIAC SURGICAL PROCEDURES; CYTOKINES; FEMALE; HUMANS; INFLAMMATION MEDIATORS; LIPIDS; LUNG INJURY; MALE; MIDDLE AGED; OPERATIVE BLOOD SALVAGE; PROSPECTIVE STUDIES; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; RESPIRATION, ARTIFICIAL; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; UTEROGLOBIN;

EID: 84961254615     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1093/icvts/ivv355     Document Type: Article

References (25)

1. Carless PA, Henry DA, Moxey AJ, O'Connell D, Brown T, Fergusson DA. Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2010;4:CD001888.
2. Wang G, Bainbridge D, Martin J, Cheng D. The efficacy of an intraoperative cell saver during cardiac surgery: a meta-analysis of randomized trials. Anesth Analg 2009;2:320-30.
3. Ng CSH, Wan S, Yim APC, Arifi AA. Pulmonary dysfunction after cardiac surgery. Chest 2002;4:1269-77.
4. Verrier ED, Boyle EM. Endothelial cell injury in cardiovascular surgery. Ann Thorac Surg 1996;3:915-22.
5. Miller BE, Levy JH. The inflammatory response to cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1997;3:355-66.
6. Damgaard S, Nielsen CH, Andersen LW, Bendtzen K, Tvede M, Steinbrüchel DA. Cell saver for on-pump coronary operations reduces systemic inflammatory markers: a randomized trial. Ann Thorac Surg 2010;5:1511-7.
7. Amand T, Pincemail J, Blaffart F, Larbuisson R, Limet R, Defraigne JO. Levels of inflammatory markers in the blood processed by autotransfusion devices during cardiac surgery associated with cardiopulmonary bypass circuit. Perfusion 2002;2:117-23.
8. Svenmarker S, Engström KG. The inflammatory response to recycled pericardial suction blood and the influence of cell-saving. Scand Cardiovasc J 2003;3:158-64.
9. Vermeijden WJ, van Klarenbosch J, Gu YJ, Mariani MA, Buhre WF, Scheeren TWL et al. Effects of cell-saving devices and filters on transfusion in cardiac surgery: a multicenter randomized study. Ann Thorac Surg 2015;1:26-32.
10. Westerberg M, Bengtsson A, Jeppsson A. Coronary surgery without cardiotomy suction and autotransfusion reduces the postoperative systemic inflammatory response. Ann Thorac Surg 2004;1:54-9.
11. De Haan J, Boonstra PW, Monnink SH, Ebels T, van Oeveren W. Retransfusion of suctioned blood during cardiopulmonary bypass impairs hemostasis. Ann Thorac Surg 1995;4:901-7.
12. Djaiani G, Fedorko L, Borger MA, Green R, Carroll J, Marcon M et al. Continuous-flow cell saver reduces cognitive decline in elderly patients after coronary bypass surgery. Circulation 2007;17:1888-95.
13. Allen SJ,McBride WT, McMurray TJ, Phillips AS, Penugonda SP, Campalani G et al. Cell salvage alters the systemic inflammatory response after off-pump coronary artery bypass grafting surgery. Ann Thorac Surg 2007;2: 578-85.
14. Ginzberg HH, Cherapanov V, Dong Q, Cantin A, McCulloch CA, Shannon PT et al. Neutrophil-mediated epithelial injury during transmigration: role of elastase. Am J Physiol Gastrointest Liver Physiol 2001;3: G705-17.
15. Arnhold J, Flemmig J. Human myeloperoxidase in innate and acquired immunity. Arch Biochem Biophys 2010;1:92-106.
16. Usatyuk PV, Natarajan V. Regulation of reactive oxygen species-induced endothelial cell-cell and cell-matrix contacts by focal adhesion kinase and adherens junction proteins. Am J Physiol Lung Cell Mol Physiol 2005;6: L999-1010.
17. Schuster DP. ARDS: clinical lessons from the oleic acid model of acute lung injury. Am J Respir Crit Care Med 1994;1:245-60.
18. Booke M, Fobker M, Fingerhut D, Storm M, Mortlemans Y, Van Aken H. Fat elimination during intraoperative autotransfusion: an in vitro investigation. Anesth Analg 1997;5:959-62.
19. Arsalane K, Broeckaert F, Knoops B, Wiedig M, Toubeau G, Bernard A. Clara cell specific protein (CC16) expression after acute lung inflammation induced by intratracheal lipopolysaccharide administration. Am J Respir Crit Care Med 2000;5:1624-30.
20. Michel O, Murdoch R, Bernard A. Inhaled LPS induces blood release of Clara cell specific protein (CC16) in human beings. J Allergy Clin Immunol 2005;6:1143-7.
21. Engels GE, van Oeveren W. Biomarkers of lung injury in cardiothoracic surgery. Dis Markers 2015:1-10.
22. Tuinman PR, Cornet AD, Kuipers MT, Vlaar AP, Schultz MJ, Beishuizen A et al. Soluble receptor for advanced glycation end products as an indicator of pulmonary vascular injury after cardiac surgery. BMC Pulm Med 2013;13:76.
23. Lomas DA, Silverman EK, Edwards LD, Miller BE, Coxson HO, Tal-Singer R. Evaluation of serum CC-16 as a biomarker for COPD in the ECLIPSE cohort. Thorax 2008;12:1058-63.
24. Pilette C, Godding V, Kiss R, Delos M, Verbeken E, Decaestecker C et al. Reduced epithelial expression of secretory component in small airways correlates with airflow obstruction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;1:185-94.
25. Smith DJ, Yerkovich ST, Towers MA, Carroll ML, Thomas R, Upham JW. Reduced soluble receptor for advanced glycation end-products in COPD. Eur Respir J 2011;3:516-22.